Can ID Migraine (TM) be used as a screening test for adolescent migraine?

Zarifoglu M., Karli N., Taskapilioglu O.

CEPHALALGIA, vol.28, no.1, pp.65-71, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 28 Issue: 1
  • Publication Date: 2008
  • Doi Number: 10.1111/j.1468-2982.2007.01470.x
  • Journal Name: CEPHALALGIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.65-71
  • Bursa Uludag University Affiliated: No


Although the ID Migraine(TM) has been developed and used for adults, it can also be used in adolescents. We aimed to investigate the validity of the ID Migraine(TM) in the adolescent student population. The study was performed on 1064 adolescents aged 12-17 years. A face-to-face semistructured interview was conducted with students after they had answered a 17-item questionnaire on sociodemographics and headache. Students who had had two or more headache attacks during the last 3 months then answered the ID Migraine(TM). The sensitivity and specificity of the ID Migraine(TM) were 62.1% and 71.1%, respectively. The sensitivity was higher for patients with migraine with aura (71.1%), for girls (71.3%) and for younger adolescents (69.1%). The specificity was higher for boys (77.9%) and for older adolescents (73.3%). The kappa value was 0.316 (P < 0.001). Although the kappa value of the ID Migraine(TM) is low, the test may be a useful tool in screening adolescent migraine after some changes are made.